← All organizations
Highest phase reached
Phase 1
First clinical trial
Jul 2, 2020Last known activity
Dec 27, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (27 distinct, 17 trials)
Phase 1 (27 own, 0 via acquisition)
Indications
Studied for
Recent trials (17)
- NCT07277712OfficialPhase 1Dec 27, 2025
- NCT06623526OfficialPhase 1Oct 4, 2024
- NCT06518122OfficialPhase 1Aug 31, 2024
- NCT06357910OfficialPhase 1May 17, 2024
- NCT06346184OfficialPhase 1May 2, 2024
- NCT05881707Overall official - principal investigatorPhase 1Jul 4, 2023
- NCT05862090Overall official - principal investigatorPhase 1Apr 5, 2023
- NCT05737082Overall official - principal investigatorPhase 1Mar 10, 2023
- NCT05723510OfficialPhase 1Mar 6, 2023
- NCT05548543Overall official - principal investigatorPhase 1Nov 19, 2022
- NCT05548387Overall official - principal investigatorPhase 1Oct 1, 2022
- NCT05188378Overall official - principal investigatorPhase 1Dec 22, 2021
- NCT04961905Overall official - principal investigatorPhase 1Sep 30, 2021
- NCT04946903Overall official - principal investigatorPhase 1Jun 10, 2021
- NCT04764201Overall official - principal investigatorPhase 1Jan 16, 2021
Details
- Last known activity
- Dec 27, 2025